Skip to Content

par 545 (Ranitidine 300 mg)

Pill imprint par 545 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; duodenal ulcer; erosive esophagitis; gastric ulcer maintenance treatment; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 300 mg par 545  Front
Ranitidine hydrochloride 300 mg par 545  Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride
par 545
300 mg
14.00 mm
Elliptical / Oval
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Par Pharmaceutical Inc.
National Drug Code (NDC):
Inactive Ingredients:
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
titanium dioxide
triethyl citrate
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0253 Amerisource Health Services
54868-4350 Physicians Total Care Inc (repackager)
49999-0428 Lake Erie Medical and Surgical Supply (repackager)
68115-0404 Dispensexpress Inc (repackager)
63874-0428 Altura Pharmaceuticals Inc (repackager)
66267-0452 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.